BRIEF-Dynavax says FDA has scheduled Sept 15 as action date for heplisav-b
March 30, 2016 at 17:17 PM EDT
March 30 (Reuters) - Dynavax Announces Fda Acceptance For Review Of Biologics License Application And Pdufa Action Date For Heplisav
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.